The Use of Simvastatin, an HMG CoA Reductase Inhibitor, in Older Patients with Hypercholesterolemia and Atherosclerosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-5415|38|1|10-14

ISSN： 0002-8614

Source： JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol.38, Iss.1, 1990-01, pp. : 10-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HMG-CoA Reductase Inhibitor Simvastatin Inhibits Proinflammatory Cytokine Production from Murine Mast Cells

By  

International Archives of Allergy and Immunology, Vol. 146, Iss. 1, 2008-05 ,pp. : 61-66

Karger

Access to resources Recommend Favorite

Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors: Is the Endothelium the Main Target?

By  

Cardiology, Vol. 95, Iss. 1, 2001-05 ,pp. : 9-13

Karger

Access to resources Recommend Favorite

Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia

By Daskalopoulou Stella S.   Mikhailidis Dimitri P.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2037-2039

Informa Healthcare

Access to resources Recommend Favorite

Effect of HMG-CoA Reductase Inhibitors (Statins) on Bone Mineral Density

By Funkhouser H.L.   Adera T.   Adler R.A.  

Journal of Clinical Densitometry, Vol. 5, Iss. 2, 2002-06 ,pp. : 151-158

Humana Press, Inc

Access to resources Recommend Favorite